Advisory Board
Sitaramaraju Yarramraju, Founder and Chief Executive Officer of Avant Santé Research Center SA de CV, Mexico. He has experience on regulatory & clinical development strategy and operations for innovator and semi-innovator drugs. His firm is actively involved in trials for COVID-19 infected patients and is a significant investor in our trials.
Dr. Thomas Klein, Chief Executive Officer and Business Director of the Research Center Pharmaceutical Engineering GmbH (RCPE), Europe’s leading research center for pharmaceutical process and product design. Dr. Klein Co-Founded RCPE in 2008. He is presently Chairman of the Wertheim Privatstiftung (Wertheim Foundation) and he is acting as a Business Mentor for several Start Up companies in the field of Life-Science solutions.
Prof. Dr. Johannes Khinast is Professor at TUGraz (Austria) and the head of the Institute for Process and Particle Engineering and Dr. Khinast is the author of more than 300 peer reviewed papers and the Chief Executive Officer and Scientific Director, The Research Center Pharmaceutical Engineering GmbH (RCPE), Europe's leading research center for pharmaceutical process and product design. Dr. Khinast Co-Founded RCPE together with Dr. Thomas Klein in 2008.
Arun J. Sanyal M.B.B.S. MD, Professor, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, is an experienced investigator who is participating in clinical COVID-19 disease trials. In 2020 he enrolled patients and managed a Remdesivir trial for COVID-19. He is a senior faculty member in various departments within Virginia Commonwealth University, holding professorships in research and teaching, and had been chairman of the departments. His scientific accomplishment includes over 234 publications in International Journals, 3 book, 35 book chapters, 224 abstracts reviewed for publication, 176 invited reviews and editorials in peer-reviewed journals, and 357 invited lectures.
Harm Jan Bogaard MD, PhD, Professor of Experimental Pulmonary Medicine, Pulmonologist. Department of Pulmonary Medicine, University Medical Centers, Amsterdam. Dr. Bogaard is a very well accomplished scientist and practicing doctor with over 192 publications in International Journals, 81 invited lectures, 6 Oral abstract presentations at international meetings, and has contributed to 13 books in the area of Pulmonary Arterial Hypertension, Lung Disease and Right Heart Failure. He is presently conducting a multi-center treatment trial of hospitalized patients with COVID-19 associated disease.